Abstract

Background and objectives: There is still an uncertainty regarding the clinical symptomatology and the diagnostic criteria in terms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), as different diagnostic criteria exist. Our aim is to identify the core symptoms of ME/CFS in the outpatient setting in Riga; to distinguish symptoms in patients with ME/CFS and those with symptoms of fatigue; and to investigate patient thoughts on the onset, symptoms, treatment and effect of ME/CFS. Materials and methods: Total of 65 Caucasian patients from an ambulatory care setting were included in the study. Questionnaires, specialist evaluation of the patients and visual analogue scale (VAS) measurements were used to objectify the findings. Results: The study showed that ME/CFS with comorbidities is associated with a more severe disease. A negative correlation was found regarding an increase in age and number of current symptoms, as well as an increase in VAS score and the duration of fatigue and age in the ME/CFS without comorbidities group. Conclusions: Comorbidities tend to present with a more severe course of ME/CFS. Fatigue, myalgia, arthralgia and sleep disturbances tend to be more prevalent in the ME/CFS patients compared to the non-ME/CFS patients. VAS score has a tendency to decrease with age and duration of fatigue. Nonsteroidal anti-inflammatory drugs are the most commonly used pharmacological drug class that reduces ME/CFS symptoms.

Highlights

  • In our study we found that there is a negative correlation regarding the age and current symptoms identified by the patients in the myalgic encephalomyelitis/chronic fatigue syndrome (ME/chronic fatigue syndrome (CFS)) group without comorbidities, indicating that more symptoms are identified by younger patients

  • Myalgia, arthralgia and sleep disturbances are the symptoms that have a tendency to be more prevalent in the Myalgic encephalomyelitis (ME)/CFS compared to the non-ME/CFS patients

  • Symptoms in the ME/CFS group without comorbidities tend to decrease by increasing age, as well as more consequences of fatigue are identified by males in both—the non-ME/CFS group and the ME/CFS group without comorbidities

Read more

Summary

Introduction

Myalgic encephalomyelitis (ME) or chronic fatigue syndrome (CFS) is post-viral or post-infectious fatigue syndrome or systemic exertional intolerance disease (SEID) that affects the functioning ability of a person and reduces the energy below the level that is considered the average. It is a complex and multifactorial disease that dysregulates the central nervous system, immune system and cellular energy metabolism, and influences physical and cognitive state [1].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call